Chitosan low molecular weight (20-200 mpa.s)
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Chitosan low molecular weight (20-200 mpa.s)
- DrugBank Accession Number
- DB14155
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Synonyms
- Poliglusam low molecular weight (20-200 mpa.s)
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Chi-Myst Resolve Topical Chitosan low molecular weight (20-200 mpa.s) (0.1 g/100mL) + Bupivacaine hydrochloride (0.3 g/100mL) + Ketorolac tromethamine (0.3 g/100mL) + Lidocaine hydrochloride (5 g/100mL) Spray, metered Topical Prescription Care Llc 2016-06-01 Not applicable US Chi-Myst Resolve Topical Chitosan low molecular weight (20-200 mpa.s) (0.03 g/30mL) + Bupivacaine hydrochloride (0.09 g/30mL) + Ketorolac tromethamine (0.09 g/30mL) + Lidocaine hydrochloride (50 g/30mL) Spray, metered Topical Prescription Care Llc 2016-06-01 Not applicable US Chi-Myst Synergy Topical Chitosan low molecular weight (20-200 mpa.s) (0.03 g/30mL) + Bupivacaine hydrochloride (0.09 g/30mL) + Ketorolac tromethamine (0.45 g/30mL) + Lidocaine hydrochloride (1.5 g/30mL) Spray, metered Topical Prescription Care Llc 2016-06-01 Not applicable US Chi-Myst Synergy Topical Chitosan low molecular weight (20-200 mpa.s) (0.1 g/100mL) + Bupivacaine hydrochloride (0.3 g/100mL) + Ketorolac tromethamine (1.5 g/100mL) + Lidocaine hydrochloride (5 g/100mL) Spray, metered Topical Prescription Care Llc 2016-06-01 Not applicable US Chi-Myst Topical Chitosan low molecular weight (20-200 mpa.s) (0.1 g/100mL) + Bupivacaine hydrochloride (0.3 g/100mL) + Ketorolac tromethamine (0.3 g/100mL) Spray, metered Topical Prescription Care Llc 2016-08-19 Not applicable US
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- SBD1A2I75N
- CAS number
- 9012-76-4
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 3 Completed Treatment Caries / Caries Class I / Dental Decay / Dentin Caries / Pulpitis - Reversible / Pulpitis dental 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Spray, metered Topical - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at June 28, 2018 22:50 / Updated at June 12, 2020 16:53